Puberty blocker trial halted over safety concerns
Work on NHS England’s planned puberty blocker trial has been paused after the medicines regulator raised concerns over its safety and efficacy.
Work on NHS England’s planned puberty blocker trial has been paused after the medicines regulator raised concerns over its safety and efficacy.
Campaigners have urged people to have conversations about organ donation, in light of the failure of the controversial opt-out model.